Use of an oscillatory positive expiratory pressure device alone or with additional airway clearance improved lung function among children with cystic fibrosis, according to data presented at the North ...

The global oscillating positive expiratory pressure (OPEP) device market is experiencing significant growth, with recent analyses projecting its valuation to reach USD 151.30 million by the end of ...

In 2025, a staggering number of individuals, in the millions, are grappling with chronic respiratory issues. Conditions such as asthma, COPD, bronchitis, and post-COVID complications are on the rise, ...

Adjunctive therapy with a positive expiratory pressure (PEP) device may possibly decrease the length of hospital stays for patients with acute exacerbation of chronic obstructive pulmonary disease ...

A large variety of airway clearance devices are commercially available, the two most recent being the Quake® and the Lung Flute®. The Quake is a pipe-shaped oscillatory PEP device that bears some ...

As per DelveInsight estimates, North America is anticipated to dominate the global airway clearance devices for cystic fibrosis market during the forecast period. In the device type segment of airway ...

DUBLIN--(BUSINESS WIRE)--The "Oscillating Positive Expiratory Pressure (OPEP) Devices Market- Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The Business Research Company's Global Airway Clearance Devices Market for Cystic Fibrosis (2025-2034): Growth Drivers, Trends, Segments & Market Share It will grow to $3.48 billion in 2029 at a ...

The adoption of OPEP devices for pediatric and geriatric populations is gaining traction in Japan creating a substantial market demand. Strengthening demand for OPEP devices in home healthcare ...

The discordance between the current practice of routinely prescribing ACTs for patients with COPD, particularly during an AECOPD, and an increasing body of evidence that suggests its clinical impact ...